Be fair. One of the Directors is the CEO so that's inclusive of the main executive salary.
The raising is a success, insofar as they raised what they hoped to. Investors have expressed confidence in this business and have supported it for at least another year. We will see soon who those investors are. Remember, no brokers involved and likely no institutions.
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-86
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.31M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $71.73K | 9.545M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 31559896 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2461710 | 6 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |